yl23455永利官网

      洞察市场格局
      解锁药品研发情报

      免费客服电话

      18983288589
      医药数据查询

      【ChiCTR2000040265】Impact of COVID-19 pandemic on Hepatobiliary and Pancreatic surgical services

      基本信息
      登记号

      ChiCTR2000040265

      试验状态

      结束

      药物名称

      /

      药物类型

      /

      规范名称

      /

      首次公示信息日的期

      2020-11-26

      临床申请受理号

      /

      靶点

      /

      适应症

      Hepatopancreaticobiliary disease

      试验通俗题目

      Impact of COVID-19 pandemic on Hepatobiliary and Pancreatic surgical services

      试验专业题目

      Impact of COVID-19 pandemic on Hepatobiliary and Pancreatic surgical services

      申办单位信息
      申请人联系人
      申请人名称
      联系人邮箱
      联系人邮编

      308433

      联系人通讯地址
      临床试验信息
      试验目的

      The hepato-pancreato-biliary (HPB) unit had to scale down the clinical workload and reallocate resources to combat COVID-19. We report local audit evaluating the impact of COVID-19 on the unit and its impact on cancer surgery.

      试验分类
      试验类型

      连续入组

      试验分期

      回顾性研究

      随机化

      Retrospective study, no randomisation done

      盲法

      /

      试验项目经费来源

      NIL

      试验范围

      /

      目标入组人数

      200;347

      实际入组人数

      /

      第一例入组时间

      2019-01-01

      试验终止时间

      2020-06-30

      是否属于一致性

      /

      入选标准

      Methods We performed a comparative audit of the HPB team surgical workload for January-June 2019 (baseline) and 2020 (COVID-19). Elective and emergency cases performed under general anesthesia were audited. Elective cases included hernia surgeries, biliary surgeries (cholecystectomy and complex biliary resections), liver, and pancreatic resections. Emergency cases included cholecystectomies and laparotomies performed for general surgical indications.;

      排除标准

      We excluded endoscopy and procedures done under local anaesthesia.;

      研究者信息
      研究负责人姓名
      试验机构

      Nil

      研究负责人电话
      研究负责人邮箱
      研究负责人邮编

      308433

      联系人通讯地址

      Nil的其他临床试验

      更多

      新加坡陳篤生醫院的其他临床试验

      更多

      最新临床资讯

      yl23455永利官网企业版
      50亿+条医药数据随时查
      7天免费试用
      体验产品